Quantum Biosystems
Latest round
- Series B
Last raised
- Feb 2015
Total raised
- $26M
Investors
- 5
About Quantum Biosystems
Founded in 2013 in Osaka, Japan, Quantum Biosystems specializes in biosystems technology. The company has executed 5 deals, with its most recent transaction occurring on April 18, 2022.Quantum Biosystems specializes in advanced biosystems technology, focusing on the development and commercialization of innovative products designed for various applications in the life sciences sector. Their core product offerings include high-performance biosensors, diagnostic tools, and analytical instruments that facilitate real-time monitoring and analysis of biological samples. These products aim to solve critical challenges in healthcare, environmental monitoring, and research, providing end users with efficient and reliable data to support decision-making. The company's clientele includes research institutions, hospitals, and laboratories, primarily in North America, Europe, and parts of Asia, where they cater to a growing need for precision and accuracy in biological analysis.The revenue model of Quantum Biosystems is structured around direct sales and strategic partnerships, enabling the company to effectively monetize its innovative products. Transactions typically occur through direct sales to research institutions and healthcare facilities, as well as subscription-based services for ongoing software and product support. The company offers various pricing plans that cater to different client needs, with flagship products commanding premium pricing due to their advanced features and reliability. This structure enhances customer retention and upselling opportunities, fostering long-term relationships with clients who require continuous access to cutting-edge biosystems technology.As of April 2022, Quantum Biosystems has discontinued its operations, indicating a significant shift in its business strategy. The company is no longer pursuing the development of new products or expansion into new markets.
Who invested in Quantum Biosystems
5 investors across 3 rounds
See all investors in Quantum Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Quantum Biosystems
Who invested in Quantum Biosystems?
Quantum Biosystems has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Quantum Biosystems raised?
Quantum Biosystems has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Quantum Biosystems last raise money?
Quantum Biosystems's most recent round on record is a Series B, in Feb 2015.
What does Quantum Biosystems do?
Founded in 2013 in Osaka, Japan, Quantum Biosystems specializes in biosystems technology.
Where is Quantum Biosystems headquartered?
Quantum Biosystems is headquartered in Osaka, Japan.
Which VCs invest in companies like Quantum Biosystems?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Quantum Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Quantum Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.